Detroit Medical Center’s Danny Benjamin, M.D., FACOG, Chief of Obstetrics and Gynecology at DMC Huron Valley-Sinai Hospital, is the first to provide the uterus-preserving, outpatient treatment option to women in Michigan Redwood City, CA, January 21, 2021 – Gynesonics®, a women’s healthcare
Sonata, a New Innovative, Incision-Free Treatment for Symptomatic Uterine Fibroids, has been Introduced in the MedStar Health System
MedStar Health is the first health system to provide Sonata, an incision-free, uterus-preserving, outpatient treatment option for women in the Maryland and Washington D.C. area Redwood City, CA - December 21, 2020 - Gynesonics®, a women’s healthcare company focused on the development of minimally
Sonata, A New Innovative, Incision-Free Procedure To Treat Symptomatic Uterine Fibroids, Expands in New York Area
Treatment provides women with a uterus-preserving, incision-free, outpatient option with significant symptom relief and fast recovery Redwood City, October 27, 2020 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine
Gynesonics Announces Publication of Long Term Three-Year Results of the SONATA FDA IDE Pivotal Trial
Outcomes Demonstrate Significant and Sustained Symptom Relief, High Patient Satisfaction, Improved Quality of Life and Low Reintervention Rates Redwood City, CA, October 13, 2020 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic
Gynesonics Introduces Sonata in Prominent New York City Fibroid Center
Sonata System Offers Innovative Incision-Free Fibroid Treatment Option For Women Suffering from Symptomatic Uterine Fibroids Redwood City, Calif., September 22, 2020 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine
Gynesonics Announces Brigham and Women’s Faulkner Hospital Becomes the First in Massachusetts to Offer Innovative New Procedure to Treat Symptomatic Uterine Fibroids
Sonata Treatment provides patients with an incision-free, outpatient option with exceptional results and fast recovery Redwood City, Calif. – September 3, 2020 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids,
Gynesonics Announces Publication of OPEN Clinical Trial Results, Demonstrating No Intrauterine Adhesion Formation Following Treatment with the Sonata System
Clinical Study Demonstrates No Adhesion Formation at Second-Look Hysteroscopy Performed Six Weeks After Transcervical Fibroid Ablation with the Sonata System Redwood City, Calif. – August 20, 2020 – Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions
Medical Device Executive Nelson Whistance Joins Gynesonics as Vice President of U.S. Sales
Redwood City, CA – August 17, 2020 – Gynesonics, a women’s healthcare company focused on the development of minimally-invasive solutions for symptomatic uterine fibroids, announced today that medical device executive Nelson Whistance has been named Vice President of U.S. Sales. Mr. Whistance
